Innovative Industrial: Buy The 13% Yield And Its 9% Preferred Stock Ahead Of Potential Cannabis Rescheduling
Innovative Industrial sees near-term risks, but low debt, solid yield, and cannabis catalysts support long-term value. Learn why IIPR stock is a strong buy.
Quant Buys In Cannabis
Cannabis has bipartisan support, but is it worthy of investment? Quant Strategist Emma Johnston covers how quant thinks about cannabis stocks and ETF MSOS.
Buy GrowGeneration – Trump Administration Considers Less Dangerous Drug Status For Cannabis
Upside for GrowGeneration hinges on cannabis rescheduling and removal of 280E taxation, which would benefit its core customers. Learn more about GRWG stock here.
Why Tilray (TLRY) Stock Is Down Today
What Happened? Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 4.6% in the morning session after reports revealed Department of Justice canceled pending cannabis rules. This regulatory …
Pot Stocks Rallied Hard in August: Is There More to Come?
Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here. The post Pot Stocks Rallied Hard in August: Is There More to Come? appeared first on The Motley Fool Canada.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Should You Buy This Stock After It Recorded a Surprise Profit?
It did not take long for the market to erase some of the gains Tilray racked up thanks to its better-than-expected quarterly update. That’s because in a Securities and Exchange Commission filing, the …
Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use
A Marijuana Moment report cites findings from a new study showing medical cannabis legalization leads to significant reductions in opioid prescriptions.
Tilray Reports Strong Q1-2026 Earnings As The Cannabis Sector Rallies
Tilray Brands, Inc. posts strong Q1-2026 results with net income & revenue growth, rallying cannabis stocks. Learn more about TLRY stock here.
Pot Stocks Get New Bull at Canaccord on Regulatory Hopes
After a years-long slump the cannabis industry is ready for a second look, according to a Canaccord Genuity analyst who kicked off coverage by rating four out of five cannabis stocks as buys.
MSOS: Cannabis Investors Betting Big On Trump
Cannabis stocks surge as rescheduling optimism grows. Learn how MSOS ETF drove gains and what future moves could mean for investors.
Pot Stocks Plunge After Rally: Is Betting on Rescheduling Worth the Risk?
From Hype to Hiccups in the Cannabis Craze Once hailed as the “next big thing,” cannabis stocks in 2018-2019 were the artificial intelligence stock darlings of their day, riding a wave of euphoria …
Analysts Love This Cannabis Penny Stock in August 2025
One of the most forgotten-about sectors many investors may have simply forgotten about is cannabis. Once touted as a high-growth sector that should benefit from regulatory stability over the long-term …
Tilray Brands: Path To 5x Growth For TLRY Stock
If a Schedule III reclassification occurs, Tilray’s revenues could potentially double within three years, with valuation multiples expanding as regulatory risks …
Is Tilray stock a Buy? TLRY soars over 16% amid optimism about US cannabis regulatory changes and European expansion
Tilray Brands Inc stock saw a rise. This happened because of possible changes in US rules about cannabis. Jefferies gave Tilray a better price target. Donald Trump may change how marijuana is …
Recent Comments